Mostrando ítems 141-160 de 468

    ESMO Recommendations on clinical reporting of genomic test results for solid cancers 

    van de Haar, Joris; Roepman, Paul; andre, fabrice; Castro, Elena; Chakravarty, Debyani; Balmaña, Judith; Dienstmann, Rodrigo; Mateo, Joaquin (Fecha de publicación: 2024-10-31)

    Genomics; Next-generation sequencing; Targeted therapies

    Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination–proficient ovarian cancer 

    Schab, Angela; Compadre, Amanda; Drexler, Rebecca; loeb, Megan; Rodriguez, Kevin; Brill, Joshua; Serra, Violeta (Fecha de publicación: 2025-07-11)

    DNA repair; Molecular diagnosis; Oncology

    SENSE EPI reconstruction with 2D phase error correction and channel-wise noise removal 

    Powell, Elizabeth; Schneider, Torben; Battiston, Marco; Toosy, Ahmed; Clayden, Jonathan D.; Gandini Wheeler-Kingshott, Claudia A.M.; Grussu, Francesco (Fecha de publicación: 2022-10-06)

    Nyquist ghost; Denoising; Diffusion

    Evolving and Improving the Sustainability of Molecular Tumor Boards: The Value and Challenges 

    Bartels, Marius; Chibaudel, Benoist; Dienstmann, Rodrigo; Lehtiö, Janne; Piccolo, Alberta; Michielin, Olivier (Fecha de publicación: 2025-02-17)

    Molecular tumor board; Molecularly guided therapy; Precision oncology

    Machine learning techniques to estimate the degree of binder activity of reclaimed asphalt pavement 

    Botella, Ramon; Lo Presti, Davide; Vasconcelos, Kamilla; Martínez, Adriana H.; Miró, Rodrigo; Bernatowicz, Kinga (Fecha de publicación: 2022-10-18)

    Recycling; Machine learning; Artificial neural networks

    Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemia 

    Medina-Gil, Daniel; Palomo Diaz, Laura; Lázaro, Gonzalo; Martín Mur, Beatriz; Hernández Pascual, Cristina; Castells, Oriol; Sánchez, Belén; Pagès Geli, Carlota; Pujadas, Gemma; Crespo, Marta; Navarro Garces, Victor; Muñoz-Torres, Pau Marc; Cabirta, Alba; Abrisqueta, Pau; Bosch, Francesc (Fecha de publicación: 2025-09-02)

    Bruton tyrosine kinase covalent inhibition; Immune microenvironment; Chronic lymphocytic leukemia

    ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility 

    de la Fuente Vivas, Dalia; CAPPITELLI, VINCENZO; García Gómez, Rocío; Valero Díaz, Sara; Amato, Camilla; Rodriguez, Javier; Duro Sánchez, Santiago; Arribas, Joaquin (Fecha de publicación: 2025-03-06)

    MAP kinases; Cell motility; Scaffold proteins

    Dose optimization in cancer drug development: Review and outcome of a multi-stakeholder workshop 

    Glasmacher, Axel; Gwaltney, Chad; Rupalla, Katrin; Li, Chunze; Weber, Harald; GARRALDA, Elena (Fecha de publicación: 2025-09-16)

    Delayed toxicity; Dose optimization; Targeted therapies

    Carm1-arginine methylation of the transcription factor C/EBPα regulates transdifferentiation velocity 

    Torcal Garcia, Guillem; Kowenz-Leutz, Elisabeth; TIAN, TIAN; Klonizakis, Antonis; Lerner, Jonathan; de Andres-Aguayo, Luisa; Vila-Casadesús, Maria; Peiró, Sandra (Fecha de publicación: 2023-06-29)

    Developmental biology; Gene regulation; Transcription factor

    Atypical pattern of response in rectal cancer after neoadjuvant pembrolizumab treatment: a case report, literature review, and proposed management model 

    Tissera, Natalia Soledad; Esteso, Federico; Luca, Romina; Enrico, Diego; Waisberg, Federico; Rodríguez, Andrés (Fecha de publicación: 2023-09-14)

    Rectal cancer; Neoadjuvant; Pembrolizumab

    Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia 

    De Asis Tuazon, Anna Marie; Lott, Paul; Bohórquez, Mabel; Benavides, Jennyfer; Ramirez, Carolina; Criollo, Angel; Diez Gibert, Orland (Fecha de publicación: 2021-09-10)

    Càncer de mama; Mutació fundadora; Haplotip

    Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA 

    Sumanasuriya, Semini; Parr, Harry; Christova, Rossitza; Pope, Lorna; Bertan, Claudia; Mateo Valderrama, Joaquim; Seed, George (Fecha de publicación: 2022-03-14)

    Cabazitaxel; Cell-free DNA; Tumour fraction

    Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial 

    Porcu, Luca; Agbor-Tarh, Dominique Akong; CINIERI, Saverio; Franzoi, Maria Alice; Di Cosimo, Serena; Saura Manich, Cristina; De Santis, Maria Carmen (Fecha de publicación: 2021-09-10)

    Índex de massa corporal; Càncer de mama HER2-positiu; Tractament neoadjuvant

    Accrual and statistical power failure in published adjuvant phase III oncology trials: a comprehensive analysis from 2013 to 2023 

    Dennett, S.; Mello, E.; Holton, J.; Lai, Xiaoran; Villacampa Javierre, Guillermo; Kilburn, Lucy (Fecha de publicación: 2024-07-02)

    Accrual failure; Oncology; Phase III

    Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer 

    Prat, Aleix; GUARNERI, VALENTINA; Brasó Maristany, Fara; Sanfeliu Torres, Esther; Paré, Laia; Cortés Castan, Javier; Pascual, Tomás; Vivancos, Ana (Fecha de publicación: 2023-05-17)

    Gene expression; Breast cancer; Prognosis

    Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development 

    Navarro-Garcia, Daniel; Beets-Tan, Regina; Blomqvist, Lennart; Bodalal, Zuhir; Marcos Morales, Adrià; DEANDREIS, Desiree'; Perez-Lopez, Raquel (Fecha de publicación: 2025-05-06)

    Radiology; Artificial intelligence; Oncology

    Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype 

    Mallo, Maria del Mar; Tuechler, Heinz; Arenillas, Leonor; Raynaud, Sophie; Cluzeau, Thomas; Shih, Lee-Yung; Palomo Diaz, Laura (Fecha de publicación: 2023-05-25)

    Chromosome; Cytogenetics; Myelodysplastic syndromes

    Gene signatures in patients with early breast cancer and relapse despite pathologic complete response 

    Bruzas, Simona; Gluz, Oleg; Cortés Castan, Javier; Blohmer, Jens-Uwe; Schmid, Peter; Harbeck, Nadia (Fecha de publicación: 2022-08-16)

    Prognostic markers; Tumour biomarkers

    Pralsetinib in patients with RET fusion–positive non-small-cell lung cancer: A plain language summary of the ARROW study 

    Griesinger, Frank; Baik, Christina; Tan, Daniel; Lee, Dae Ho; Curigliano, Giuseppe; Subbiah, Vivek; GARRALDA, Elena (Fecha de publicación: 2024-03-12)

    RET fusion; Non-small cell lung cancer; Targeted therapy

    Smoking-related dysregulation of plasma circulating microRNAs: the Rotterdam study 

    Maas, Silvana; Shuai, Yu; Ikram, Mohammad Arfan; Stricker, Bruno; Aerts, Joachim; Karabegović, Irma (Fecha de publicación: 2023-08-22)

    Circulating miRNAs; Lung cancer; Smoking